Maria Antonietta Riemma

University of Campania "Luigi Vanvitelli" — Italy

Medicine · Health Sciences

12h-index421citations32works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(12), Sphingolipid Metabolism and Signaling(12), Diabetes Treatment and Management(6), Adenosine and Purinergic Signaling(5), Cardiovascular Function and Risk Factors(4)

Publications32 total

Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses
Frontiers in Pharmacology·2026Open Access
Sex hormones influence ORMDL3 expression: Implications for sex-associated asthma phenotype
Journal of Allergy and Clinical Immunology·2025Open Access
Combination of an oral H2S donor to dapagliflozin provides additional therapeutic benefit in a cardiorenal model of heart failure with preserved ejection fraction (HFpEF)
European Heart Journal·2025
SGLT2 inhibitor dapagliflozin mitigates skeletal muscle pathology by modulating key proteins involved in glucose and ion homeostasis in an animal model of heart failure
European Journal of Pharmacology·2025· 2 citedOpen Access
Effects of sacubitril-valsartan on aging-related cardiac dysfunction
European Journal of Pharmacology·2024· 4 citedOpen Access
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
Frontiers in Pharmacology·2024· 6 citedOpen Access
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch
Cancers·2023· 5 citedOpen Access
Contributors
Elsevier eBooks·2023
Neutral endopeptidase (neprilysin)
Elsevier eBooks·2023
Sphingosine 1 Phosphate Signaling Pathway Drives Female Asthma Susceptibility
2023
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome
Pharmacological Research·2023· 77 citedOpen Access
Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors
Pharmacological Research·2022· 22 citedOpen Access
Abstract P315: Nogo-a Reduces Ceramide <i>De Novo</i> Biosynthesis To Protect From Heart Failure
Hypertension·2022
Nogo-A reduces ceramide <i>de novo</i> biosynthesis to protect from heart failure
Cardiovascular Research·2022· 25 citedOpen Access
Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge
Biomolecules·2022· 7 citedOpen Access
Sphingosine-1-phosphate drives sex-dimorphism in lung function
2022
Renoprotection by Dapagliflozin in a Non-Diabetic Model of Cardiorenal Syndrome
SSRN Electronic Journal·2022Open Access
Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease
British Journal of Pharmacology·2021· 34 citedOpen Access
Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73)
Frontiers in Pharmacology·2020· 12 citedOpen Access
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse
Pharmacological Research·2020· 16 cited
page 1 of 2Next →

Frequent Co-authors

Fiorentina Roviezzo(19), Ida Cerqua(12), Giuseppe Cirino(12), Antonietta Rossi(9), Konrad Urbanek(8), Donato Cappetta(8), Liberato Berrino(8), Marialucia Telesca(7), Armando Ialenti(7), Bruno D’Agostino(7), Maria Donniacuo(6), Elena Mele(6), Elisabetta Caiazzo(6), Giuseppe Spaziano(6), Rosalinda Sorrentino(6), Gabriella Bellocchio(5), Paola Imbrici(5), Antonella De Angelis(5), Carla Cicala(5), Eleonora Cianflone(4)